These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 5398580)

  • 1. [Therapeutic effects of amantadine hydrochloride on manifestations of parkinsonism].
    Espadaler Medina JM; Olivella Rius J; Ruscadella Nadal J
    Rev Esp Otoneurooftalmol Neurocir; 1969-1970; 28(164):236-46. PubMed ID: 5398580
    [No Abstract]   [Full Text] [Related]  

  • 2. Amantadine hydrochloride in treatment of Parkinsonism.
    Nagaswami S; Nagaswami R
    Dis Nerv Syst; 1973; 34(5):253-8. PubMed ID: 4782280
    [No Abstract]   [Full Text] [Related]  

  • 3. [Experience in the prolonged use of midantan (amantadine hydrochloride) in parkinsonism].
    Man'kovskii NB; Vainshtok AB; Oleinik LI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):524-30. PubMed ID: 4705407
    [No Abstract]   [Full Text] [Related]  

  • 4. [The therapeutic effectiveness of amantadine (midantan) in parkinsonism syndromes].
    Kiseleva AM; Zlydnikov DM; Mazhinskaia VP; Lebedeva VK; Zakharova NG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1973; 73(4):530-4. PubMed ID: 4705408
    [No Abstract]   [Full Text] [Related]  

  • 5. Amantadine hydrochloride in the treatment of Parkinsonism. A controlled trial.
    Appleton DB; Eadie MJ; Sutherland JM
    Med J Aust; 1970 Oct; 2(14):626-9. PubMed ID: 4920572
    [No Abstract]   [Full Text] [Related]  

  • 6. [Current treatment of Parkinsonism with amantadine hydrochloride].
    Gerstenbrand F; Gründig E; Musiol A
    Pol Tyg Lek; 1972 Jul; 27(23):878-9. PubMed ID: 5040531
    [No Abstract]   [Full Text] [Related]  

  • 7. [Therapeutic experiences with amantadine sulfate as a monotherapeutic drug in patients with Parkinsonism].
    Völler GW; Deze J
    Z Allgemeinmed; 1973 May; 49(14):664-70. PubMed ID: 4585272
    [No Abstract]   [Full Text] [Related]  

  • 8. [Amantadine hydrochloride in patients with parkinsonism in a Geriatric Rehabilitation Center].
    Antonini FM; Baroni A
    Minerva Med; 1971 Oct; 62(82):4027-30. PubMed ID: 5125072
    [No Abstract]   [Full Text] [Related]  

  • 9. [Amandatine hydrochloride (Symmetrel) in the treatment of parkinsonism].
    Nikolić M; Lević Z
    Srp Arh Celok Lek; 1976 Feb; 104(2):113-8. PubMed ID: 1013802
    [No Abstract]   [Full Text] [Related]  

  • 10. [Treatment of parkinsonism with viregyt (amantadine)].
    Pryszmont M; Jankowicz E; Eljasz L; Slizewski M; Wiśniewska Z
    Wiad Lek; 1974 Aug; 27(15):1371-5. PubMed ID: 4418066
    [No Abstract]   [Full Text] [Related]  

  • 11. Amantadine hydrochloride in the treatment of Parkinson's disease.
    Nagaswami S; Ranjini R
    J Kans Med Soc; 1971 Nov; 72(11):465-8. PubMed ID: 5120698
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of amantadine therapy on sleep spindles in patients with parkinsonism and comparative analysis of L-dopa effects].
    Puca FM; Pigneri MT
    Boll Soc Ital Biol Sper; 1972 May; 48(9):237-40. PubMed ID: 5070096
    [No Abstract]   [Full Text] [Related]  

  • 13. [Medical treatment of Parkinson's disease with amantadine hydrochloride. Preliminary note].
    Portera A; Varela de Seijas E; Mata P; Ramírez Echevarría TJ; Amaya Pombo C
    Rev Clin Esp; 1970 Jun; 117(6):579-86. PubMed ID: 5518942
    [No Abstract]   [Full Text] [Related]  

  • 14. L-dopa treatment of parkinsonism. Clinical observations on the use of amantadine hydrochloride.
    Reveno WS; Bauer RB; Rosenbaum H
    Geriatrics; 1971 Aug; 26(8):61-70. PubMed ID: 5096462
    [No Abstract]   [Full Text] [Related]  

  • 15. [Amantadine hydrochloride in the treatment of Parkinson's syndrome].
    De la Herrán J; Figuerido JA
    Rev Esp Otoneurooftalmol Neurocir; 1971; 29(167):45-9. PubMed ID: 5091472
    [No Abstract]   [Full Text] [Related]  

  • 16. The treatment of parkinsonism with L-Dopa and amantadine.
    Green J
    J Fla Med Assoc; 1970 Jun; 57(6):28-33. PubMed ID: 5445813
    [No Abstract]   [Full Text] [Related]  

  • 17. A controlled study of the clinical effects of amantadine hydrochloride (Symmetrel).
    Merrick EM; Schmitt PP
    Curr Ther Res Clin Exp; 1973 Aug; 15(8):552-8. PubMed ID: 4200529
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of amantadine on some psychomotor performances in Parkinsonism. A double blind study.
    Laitinen LV; Vilkki J
    Ann Clin Res; 1971 Aug; 3(4):207-11. PubMed ID: 4937341
    [No Abstract]   [Full Text] [Related]  

  • 19. [Amantadine and dexetimide in the treatment of parkinsonism].
    Hakkarainen H; Viukari M
    Duodecim; 1973 Jul; 89(21):1437-41. PubMed ID: 4586970
    [No Abstract]   [Full Text] [Related]  

  • 20. [6 months of treatment with amantadine and L-Dopa. Comparison in 2 groups of patients with parkinsonism].
    Buscaino GA; Campanella G; Zallone E
    Minerva Med; 1971 Oct; 62(82):3974-8. PubMed ID: 5125057
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.